Login / Signup

Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86).

Neesha C DhaniHal W HirteLisa WangJulia V BurnierAngela JainMarcus O ButlerStephen WelchGini F FlemingJean HurteauKoji MatsuoDaniela MateiWaldo JimenezCarolyn JohnstonMihaela CristeaKatia TonkinPrafull GhatageStephanie LheureuxAnjali MehtaJudy QuintosQian TanSuzanne Kamel-ReidOlga LudkovskiMing Sound TsaoJohn J WrightAmit M Oza
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Cabozantinib has activity in serous and endometrioid histology endometrial cancer. These results support further evaluation in genomically characterized patient cohorts.
Keyphrases
  • endometrial cancer
  • metastatic renal cell carcinoma
  • high grade
  • squamous cell carcinoma
  • small cell lung cancer